Company Dynamic

Covestro (India) and India’s Council of Scientific and Industrial Research-National Chemical Laboratory (CSIR-NCL) have signed an MoU to develop next-generation recycling solutions for polyurethane (PU) materials, aiming to overcome persistent industry bo

On July 16, Abu Dhabi National Oil Company (ADNOC) announced plans to transfer its 24.9% stake in Austria’s OMV AG to its wholly owned investment arm, XRG PJSC.

On July 21, Wanhua Chemical (600309.SH) announced that its wholly-owned subsidiary, BorsodChem Zrt. in Hungary, will initiate scheduled maintenance for its MDI (400,000 tons/year) and TDI (250,000 tons/year) production units starting July 23, 2025.

• wanhua chemical

Europe’s petrochemical sector is in turmoil, with a wave of plant shutdowns and capacity cuts threatening up to 50,000 jobs by 2035.

On July 17, Xinfengming Group and Leaf Bio held a landmark ceremony to formalize their strategic partnership, signaling a new era of collaborative innovation for the textile fiber industry.

Wanhua Chemical has recently been granted a pivotal invention patent for a novel catalyst used in the synthesis of lactide from lactic acid, with broad implications for the biodegradable plastics industry.

Zydus Lifesciences has suffered a major legal setback after the Delhi High Court issued an interim injunction halting further development and commercialization of its biosimilar to Bristol Myers Squibb’s cancer drug Opdyta (nivolumab).

Ineos has completed a major £30m (€34.6m) investment in its Hull manufacturing facility to switch to the clean fuel hydrogen instead of natural gas.

• Ineos

Manali Petrochemicals Limited (MPL), a leading petrochemicals manufacturing company and part of AM International, Singapore, has marked a major milestone with the expansion of its Propylene Glycol (PG) plant.

• Manali Petrochemicals Limited

Shiseido Americas, the U.S. subsidiary of Japan’s Shiseido Group, is undertaking a “wide‑ranging and significant” workforce reduction following a steep sales slump across 2024 and into 2025.

• Shiseido
• Americas

LBB Specialties (LBBS), a North American specialty chemicals and ingredients distributor, recently announced the expansion of its distribution partnership with Clariant.

• LBB Specialties

Diamond Edge Ventures, the corporate venture capital arm of Mitsubishi Chemical Group, announced today that it has invested in Licella Holdings, an Australian leader in advanced recycling and renewable fuel technologies.

• Mitsubishi chemical
• Licella Holdings

In the first half of 2025, Puig achieved €2.3 billion in net revenue, marking a 7.6% year-over-year increase on a like-for-like (LFL) basis and 5.9% growth on a reported basis.

• Puig

Wacker Chemie has launched its new “Next” etching line for producing ultra‑pure, semiconductor‑grade polysilicon at its Burghausen site in Germany—an investment of more than €300 million and the company’s largest project to date.

• Wacker
• Wacker Chemie

Covestro (India) Private Limited and the National Chemical Laboratory (NCL) of the Council of Scientific and Industrial Research of India have signed a Memorandum of Understanding (MoU) to initiate an innovative CSR project aimed at developing sustainable

• Covestro
• India
• CSIR-NCL

On July 15, ExxonMobil’s landmark Huizhou Ethylene Project, a major foreign investment initiative in China, officially began operations, promising to boost domestic supply for high-performance plastics.

Shenma disclosed on July 14 that it expects a net loss of approximately 37.5 million yuan for the first half of 2025, marking a sharp reversal from last year’s profit.

BASF has sharply revised down its full-year 2025 earnings forecast after releasing disappointing preliminary results for the second quarter.

Röhm Group has confirmed the closure of its 150,000-ton methyl methacrylate (MMA) plant in Westwego, Louisiana at the end of June, following the start-up of its new 250,000-ton facility in Bay City, Texas.

Emcure Pharmaceuticals has signed an exclusive agreement to distribute and promote Sanofi’s oral anti-diabetes (OAD) medicines in India, a move set to impact millions living with type-2 diabetes.